In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
In the latest session, Psyence Biomedical Ltd (NASDAQ: PBM) closed at $2.64 up 4.76% from its previous closing price of $2.52. In other words, the price has increased by $4.76 from its previous closing price. On the day, 20.26 million shares were traded. PBM stock price reached its highest trading level at $4.0 during the session, while it also had its lowest trading level at $2.6.
Ratios:
For a deeper understanding of Psyence Biomedical Ltd’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.01 and its Current Ratio is at 0.01.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 2230958 and an Enterprise Value of 10297195.
Stock Price History:
Over the past 52 weeks, PBM has reached a high of $945.15, while it has fallen to a 52-week low of $2.13. The 50-Day Moving Average of the stock is -54.95%, while the 200-Day Moving Average is calculated to be -93.27%.
Shares Statistics:
For the past three months, PBM has traded an average of 121.52K shares per day and 233879 over the past ten days. A total of 0.72M shares are outstanding, with a floating share count of 0.63M. Insiders hold about 13.57% of the company’s shares, while institutions hold 9.88% stake in the company. Shares short for PBM as of 1730332800 were 671846 with a Short Ratio of 0.09, compared to 1727654400 on 215100. Therefore, it implies a Short% of Shares Outstanding of 671846 and a Short% of Float of 1.15.
